Examples: Prince; Princeton University; Ken Follett; Follett,Ken
1shortlisttitle datasearch history  
results search [or] ISN:0000000121374333 | 1 hits
Person
ISNI: 
0000 0001 2137 4333
Name: 
Riederer, P.
Riederer, Peter
Riederer, Peter F.
Riederer, Peter Franz
Riederer, Peter Franz (Vollstaendiger Name)
Dates: 
1942-
Creation class: 
Computer file
cre
Language material
Text
Creation role: 
author
contributor
creator
editor
redactor
Related names: 
Beckmann, Helmut (1940-)
Birkmayer, W. (1910-1996)
Birkmayer, Walther (1910-1996)
Gerlach, Manfred (1954-)
Jellinger, K. (1931-)
Jellinger, Kurt (1931-)
Ludwig Boltzmann-Institut für Klinische Neurobiologie
Maurer, Konrad (1943- ))
Przuntek, Horst (1938-)
Reichmann, Heinz
Youdim, Moussa B.H.
Titles: 
Advances in research on neurodegeneration, vol. 5 : [proceedings of the Fifth International Winter Conference on Neurodegeration, Spitzingsee, Bavaria, February 1996]
Amine oxidases and their impact on neurobiology : proceedings of the 4th International amine oxidases workshop, Würzburg, Federal Republic of Germany, July 7-10, 1990
Basic aspects of receptor biochemistry : proceedings of the international symposium, Vienna, September 10-12, 1982
Current topics in extrapyramidal disorders
Depression Biochemie, Klinik, Therapie
Early diagnosis and preventive therapy in Parkinson's disease
Focus on extrapyramidal dysfunction
Handbook of Neurochemistry and Molecular Neurobiology Degenerative Diseases of the Nervous System
introduction to neurotransmission in health and disease, An
Iron in central nervous system disorders
L-Dopa-Substitution der Parkinson-Krankheit Geschichte - Gegenwart - Zukunft
MAO-B-inhibitor selegiline (R-(-)-Deprenyl) a new therapeut. concept in the treatment of Parkinson's disease ; proceedings of the internat. symposium in Berlin, January 23 - 25, 1987
Modèle de zone adapté aux essais de régulateurs de systèmes de chauffage et de climatisation
Monoamine oxidase and its selective inhibitors
Morbus Parkinson Selegilin (R-(-)-Deprenyl) ; Movergan ; e. neues Therapiekonzept
Neuro-Psychopharmaka ein Therapie-Handbuch
Neurotransmitter und menschliches Verhalten
Oxidative stress and neuroprotection
Parkinson-Krankheit Grundlagen, Klinik, Therapie, Die
Parkinson's disease biochemistry, clinical pathology, and treatment
Pathobiology and clinics of basal ganglia disorders
Pathochemical markers in major psychoses
role of brain dopamine, The
Selegiline and neuroprotection in Parkinson's disease
Understanding the neurotransmitters : key to the workings of the brain
Viertes Drei-Länder-Symposium für Biologische Psychiatrie
Notes: 
Sources: 
VIAF DNB LC LNB NTA NUKAT SUDOC WKP
TEL